XML 50 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
Licensing and Commercialization Agreement with Novartis Pharma AG (Tables)
 9 Months Ended
Sep. 30, 2015
Licensing and Commercialization Agreement with Novartis Pharma AG  
Schedule of collaboration revenue components

 

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

 

 

 

 

 

 

 

 

 

 

License revenue

 

$

—

 

$
38,373 

 

$
38,083 

 

$
38,373 

 

Research and development activity revenue

 
1,594 

 
1,200 

 
6,768 

 
1,200 

 

API transfer revenue

 
1,851 

 

—

 
1,851 

 

—

 

Joint operating committee revenue

 
3 

 
2 

 
21 

 
2 

 

 

 

 

 

 

 

 

 

 

 

Total collaboration revenue

 

$
3,448 

 

$
39,575 

 

$
46,723 

 

$
39,575